2023-11-30 · Notice · 2023-26260
Determination of Regulatory Review Period for Purposes of Patent Extension; ZEGALOGUE
Dasiglucagon
Open attributed record →Federal Register publication year
16 documents attributed to FDA and HHS and published in 2023, connected only through exact reviewed peptide-name matches.
2023-11-30 · Notice · 2023-26260
Dasiglucagon
Open attributed record →2023-11-29 · Notice · 2023-26255
Pegcetacoplan
Open attributed record →2023-11-28 · Notice · 2023-26106
Difelikefalin
Open attributed record →2023-11-17 · Notice · 2023-25485
Semaglutide
Open attributed record →2023-11-01 · Notice · 2023-24120
Daptomycin
Open attributed record →2023-09-05 · Notice · 2023-19013
Bivalirudin
Open attributed record →2023-08-24 · Notice · 2023-18241
Exenatide
Open attributed record →2023-08-24 · Notice · 2023-18250
Exenatide
Open attributed record →2023-08-22 · Notice · 2023-18026
Glucagon + Tirzepatide
Open attributed record →2023-08-07 · Notice · 2023-16775
Daptomycin
Open attributed record →2023-05-19 · Notice · 2023-10710
Difelikefalin
Open attributed record →2023-03-30 · Notice · 2023-06593
Trofinetide
Open attributed record →2023-03-01 · Notice · 2023-04175
Icatibant
Open attributed record →2023-02-17 · Notice · 2023-03364
Afamelanotide + Glucagon + Leuprolide + Vosoritide
Open attributed record →2023-02-17 · Notice · 2023-03389
Calcitonin salmon
Open attributed record →2023-02-06 · Notice · 2023-02442
Desmopressin
Open attributed record →